PARP1 and cancer: Therefore, new strategies in cancer therapy seek to inhibit PARP activity because knock-out mice for PARP-1 and -2 showed profound deficiencies in the mechanisms of DNA repair, as well as greater sensitivity to ionizing radiation or alkylating agents [130].